{"id":"W4409250038","doi":"10.1097/jcp.0000000000001990","title":"Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II","year":2025,"lang":"en","type":"letter","venue":"Journal of Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Patient-Centered Outcomes Research Institute; H. Lundbeck A/S; Centers for Disease Control and Prevention; Georgia Clinical and Translational Science Alliance; Epilepsy Society; Sunovion; Johns Hopkins University; National Institute of Mental Health; International Society for Bipolar Disorders; Teva Pharmaceutical Industries; Allergan; National Institutes of Health; HLS Therapeutics; Sage Therapeutics; Daiichi Sankyo Europe; World Health Organization; Indivior; Bristol-Myers Squibb","keywords":"Clozapine; Medicine; Neutropenia; Myocarditis; Package insert; Pharmacovigilance; Intensive care medicine; Pneumonia; Pediatrics; Psychiatry; Internal medicine; Adverse effect; Schizophrenia (object-oriented programming); Pharmacology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002598969,0.0008425367,0.0006217171,0.00065404,0.001628969,0.002791769,0.00120688,0.01962335,0.03135546],"category_scores_gemma":[0.01806083,0.00042718,0.001539939,0.0004544725,0.001203123,0.001975029,0.0007059089,0.01037421,0.01864292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002761683,"about_ca_system_score_gemma":0.004057518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006366704,"about_ca_topic_score_gemma":0.009800128,"domain_scores_codex":[0.9974664,0.0004642718,0.0002682209,0.0003395971,0.0011321,0.0003293678],"domain_scores_gemma":[0.993306,0.002304005,0.0004964161,0.00027453,0.002828982,0.000790108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004162695,0.00002524727,0.0002082809,0.00002392211,0.000007090994,0.0002010884,0.00002208725,0.00001435164,0.0002002846,0.0006153334,0.9914089,0.007231869],"study_design_scores_gemma":[0.00007742953,0.00008684467,0.001258588,0.0001046977,0.00002240687,0.0003925673,0.0001023407,0.0001241572,0.0003176422,0.0006514037,0.9968402,0.0000217588],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.00168285,0.002635997,0.0005679177,0.9076248,0.06207373,0.0001241383,0.0007027895,0.0004511456,0.02413663],"genre_scores_gemma":[0.008476862,0.00102637,0.0009513955,0.8955863,0.02412642,0.00008761173,0.0003944632,0.0001053537,0.06924524],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.03135546,"threshold_uncertainty_score":0.1048945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05870072046064749,"score_gpt":0.4370221352094761,"score_spread":0.3783214147488286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}